Ardelyx reported $-30.68M in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
Abbott USD 2.13B 281M Jun/2026
Amgen USD 4.61B 777M Jun/2026
Ardelyx USD -30.68M 35.78M Mar/2026
aTyr Pharma USD -121.47K 24.59M Mar/2026
Corcept Therapeutics USD 41.3M 90.9M Jun/2026
Curis USD -11.52M 3.64M Mar/2026
Sanofi EUR 2.18B 1.56B Mar/2026
TG Therapeutics USD 21.67M 13.12M Jun/2026
United Therapeutics USD 375.6M 49.8M Jun/2026